Entrectinib Effective Across NTRK Fusion–Positive Cancers

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2018-156
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Activity of Entrectinib in a Patient With the First Reported NTRK Fusion in Neuroendocrine Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2017English

OA02.01 Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Genomic Alterations in Mucins Across Cancers

Oncotarget
Oncology
2017English

ZW25 Active in HER2-positive Cancers

Cancer Discovery
Oncology
2018English

Membrane Protein-Regulated Networks Across Human Cancers

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Loss of the Adhesion Molecule CEACAM1 Is Associated With Early Biochemical Recurrence in TMPRSS2:ERG Fusion Positive Prostate Cancers

International Journal of Cancer
Cancer ResearchOncology
2020English

Modularized Perturbation of Alternative Splicing Across Human Cancers

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

P2.03-09 the Real World of NTRK Fusion Data in the Chinese Lung Cancer Populations: A Multicenter Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Shared Heritability and Functional Enrichment Across Six Solid Cancers

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy